𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Differentiation capacity of human non-small-cell lung cancer cell lines after exposure to phorbol ester


Book ID
122964537
Publisher
Elsevier Science
Year
1991
Tongue
English
Weight
166 KB
Volume
7
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Differentiation capacity of human non-sm
✍ Ursula Salge; Peter Kilian; Kurt Neumann; Hans-Peter Elsässer; Klaus Havemann; H 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 944 KB

## Abstract Three cell lines of squamous‐cell carcinoma and 3 of large‐cell carcinoma origin were investigated for the expression of differentiation markers and functional parameters (proliferation, morphology, cornified envelope formation, involucrin staining, transglutaminase activity, adhesivene

Control of proteinase expression by phor
✍ Marcus Schuermann; Robert Jäger; Ursula Salge; Gundula Risse-Hackl; Klaus Havema 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 289 KB 👁 2 views

Activation of protein kinase C- (PKC) and Fos/Jun-dependent signal transduction pathways are thought to be major effects of oncogene action in different tumor systems including human non-small-cell lung carcinoma (NSCLC). We have previously shown that the phorbol ester analogue phorbol-myristate-ace

Establishment of a human non-small cell
✍ Fumiaki Koizumi; Tatsu Shimoyama; Fumiko Taguchi; Nagahiro Saijo; Kazuto Nishio 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 672 KB

## Abstract The epidermal growth factor receptor (EGFR) tyrosine‐kinase inhibitor gefitinib (Iressa®, ZD1839) has shown promising activity preclinically and clinically. Because comparative investigations of drug‐resistant sublines with their parental cells are useful approaches to identifying the m